Dr. Donna D. Zhang
Donna D. Zhang received her Ph.D. from New York University in 1997. After a brief postdoctoral fellowship at the DuPont-Haskell Laboratory, she took a Research Assistant Professor position in the Biochemistry Department at the University of Missouri-Columbia. Following her time at Missouri, she joined the University of Arizona as an Assistant Professor in 2005 where she is currently a Professor in the Department of Pharmacology and Toxicology, College of Pharmacy.
Dr. Zhang’s research program focuses on investigating the key physiological and pathological roles of the Nrf2-Keap1-ARE signaling pathway in mediating disease. She has published over 130 well-received papers as evidenced by her total number of citations (20512) and h-index (56) [Google Scholar database as of January17, 2019]. Dr. Zhang has made seminal contributions to both the mechanistic understanding of Nrf2 regulation, as well as the dual role of Nrf2 in human diseases. Her work has been continuously supported by the NIH, and is both nationally and internationally recognized, including in 2012 when she received the Society of Toxicology Achievement Award.
For more information on Dr. Zhang’s research and accomplishments, check out her CV: